A procedure is described for gram-scale refolding of Escherichia coil-deriv
ed human leptin inclusion bodies. Refolding was achieved by gradually reduc
ing denaturant using a diafiltration method. Refolded leptin is characteriz
ed by in vivo modulation of food intake, reduction in body weight, and lowe
ring of insulin and glucose levels in ob/ob mice. In addition, refolded lep
tin is characterized by radioimmunoassay (RIA) and activation of the leptin
receptor in a cell-based assay. For comparison we also refolded leptin by
a simple dilution method and produced periplasmic derived leptin, which did
not require ex vivo folding. Leptin produced by these three methods and le
ptin obtained from commercial sources were compared using the RIA and the c
ell-based assay and appeared to be of comparable quality and potency. (C) 1
998 Academic Press.